there is a report that glp-1s are gaining traction for treating fatty liver disease. other reports appear to be unrelated, focusing on various medical topics such as surgical innovations, telemedicine programs, and chronic pain management. it is unclear if these unrelated reports are connected to the use of glp-1s for fatty liver disease treatment.